The FDA Supports Research and Development of the Cannabis Plant

[PrincessM]

There is sometimes a question as to the FDA\’s views on whether or not they object to the clinical investigation of Cannabis. They are in favor of studying Cannabis and feel that scientifically significant research can and should be conducted under an IND application. This is the best way to determine if the public could benefit from using Cannabis derived compounds.

The FDA supports conducting research by providing information on the process by which the clinical research is conducted. They also provide information on the exact requirements that govern the development of drugs derived from a plant such as the Cannabis plant. In December 2016, the FDA updated its rules about providing sponsors for Cannabis research with guidelines on submitting IND applications for botanical medicinal products. This publication is entitled Guidance for Industry: Botanical Drug Development.

The FDA provides support to investigators who are interested in conducting clinical research on Cannabis and its products. This occurs through the IND application process, and regular meetings and interactive sessions are held throughout the process of the drug development.

Furthermore, the FDA provides general assistance and support to the researchers to help them to understand and to follow the procedural guidelines through the FDA Center for Drug Evaluation and Research.

[Author]

Posts